U.S. Medical Equipment Stock News

NYSE:FMC
NYSE:FMCChemicals

FMC (FMC) Advances RNA Bioinsecticides, Is The Stock 25% Undervalued?

FMC Corporation (FMC) moved into the spotlight after announcing that two RNA-based bioinsecticide candidates with AgroSpheres are progressing into global field trials across the United States, Brazil and Asia. For FMC, the RNA bioinsecticide milestone is landing against a weak price backdrop, with the share price down 28.87% year to date and posting a 1-year total shareholder return decline of 71.61% as dividend cuts and past setbacks continue to weigh on sentiment. Over three and five years,...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Shares Moved, So What Is Driving Attention Now?

Attention on Dave (DAVE) has picked up as investors focus on the upcoming CashAI v5.5 rollout, which is expected to influence credit performance, advance sizes, loss rates, and overall profitability for the platform. Recent trading reflects that optimism. Dave’s 1 month share price return of 7.01% and 90 day share price return of 13.37% sit alongside a 62.42% year to date share price gain, while the 3 year total shareholder return is very large, which points to strong momentum built over...
NYSE:AJG
NYSE:AJGInsurance

Arthur J. Gallagher (AJG) Stock Looks Reasonably Priced On Earnings Returns

Arthur J. Gallagher has given long term shareholders a 67.0% gain over the past 5 years, even though the share price has fallen over the past year. That track record puts the spotlight on a simple question for today’s buyers and holders: whether the current valuation can be explained by the returns the business earns on its capital. A 67.0% return over 5 years means Gallagher has already rewarded patient investors, which raises the bar for how strong its future capital returns need to be to...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Guidance Reaffirmed Might Change The Case For Investing In Arcutis Biotherapeutics (ARQT)

Arcutis Biotherapeutics used a recent Morgan Stanley healthcare conference to reaffirm its 2026 revenue guidance of US$525 million to US$540 million and confirmed that the Phase 2 vitiligo trial remains scheduled for a fourth quarter data readout. This combination of steady revenue guidance and an on track dermatology pipeline update gives investors a clearer view of how Arcutis Biotherapeutics is trying to balance commercial execution with R&D progress. This article examines how Arcutis...
NasdaqGS:HONA
NasdaqGS:HONAAerospace & Defense

Honeywell Aerospace (HONA) Stock Looks Like A Bargain On Cash Flow

Honeywell Aerospace shares have climbed recently after a weak start to the year, which puts fresh attention on whether the current market price lines up with what the business can generate in cash over time. For investors watching the swings, the key issue is whether the stock’s recent move is backed up by the company’s underlying cash flows. The stock is still down 16.4% year to date, so the recent rebound raises the question of whether the current valuation now properly reflects the cash...
NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Stock Looks Fairly Priced Despite A 31% Drop

Blackstone has seen its share price fall sharply over the past year, which puts a spotlight on a different question for you as an investor. Is the current market value still in line with the returns the asset manager earns on the capital it puts to work across credit, private equity and real assets? The stock is down 30.8% over the past year, which raises the question of whether that decline now matches the returns Blackstone is generating on its invested capital. Recent moves to acquire...
NYSE:M
NYSE:MMultiline Retail

Macy's (M) Raises Guidance And Finishes Buyback, Is The Stock Still Below Fair Value?

Macy's (M) just paired a fresh quarter of earnings with updated guidance and a completed multiyear buyback, giving investors a dense cluster of new numbers to dissect around the stock. At around $21.64 per share, Macy's has slipped over the past month and quarter, with the 30 day and 90 day share price returns down 6.84% and 10.36%. At the same time, the 1 year total shareholder return of 27.25% and 3 year total shareholder return of about 2.3x hint that investors who stayed through earlier...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Can Constellation Energy (CEG) Justify Its Valuation Following Data Center Power Deals?

Constellation Energy (CEG) has moved into the spotlight after filing a detailed protest with the Federal Energy Regulatory Commission that challenges PJM’s proposed Interim Resource Adequacy Service and Large Load Registry framework. Recent trading in Constellation Energy reflects this push and pull between strong nuclear and data center demand tailwinds and fresh regulatory and acquisition headlines. The share price closed at US$262.8, with a 1-day share price return of 1.26%. However, the...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly Stock Gains Attention After Comcast Edge Network Deal

Comcast and Fastly announced a next generation partnership that embeds Fastly’s programmable edge software across Comcast’s nationwide network to push live streaming, security, and AI workloads closer to millions of Xfinity customers. The tie up effectively turns Comcast’s more than 200 AI powered edge compute centers into distribution points for Fastly’s platform, deepening Fastly’s role in high value, latency sensitive traffic such as live sports, gaming, and AI inference. We will look at...
NYSE:BALL
NYSE:BALLPackaging

Ball (BALL) Expands In India, Is The 16% Undervaluation Still Compelling?

Ball (BALL) is expanding its presence in India with a new beverage can facility in Uttar Pradesh. The plant is planned as a two line operation backed by customer contracts and is expected to start operations in 2029. Ball’s latest India expansion lands after a mixed price stretch, with the share price up 5.3% over 90 days and 13.9% year to date. The 1 year total shareholder return of 25.2% contrasts with a 5 year total shareholder return that remains materially lower. Scan how Ball’s India...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Chairman Role Passes From Warren Buffett To Howard Buffett

Berkshire Hathaway (NYSE:BRK.A) announced that Warren Buffett has stepped down as Chairman, effective immediately. Howard G. Buffett, Warren Buffett’s son and a long-serving Berkshire director, has been appointed as the new Chairman. Warren Buffett will remain involved with the conglomerate as Chairman Emeritus, a newly created honorary role. The handover of the Berkshire Hathaway chairmanship from Warren Buffett to Howard Buffett is only part of today’s story. We have also flagged 1 major...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

Is Airbnb (ABNB) Still Trading At A Discount After New Housing Moves?

Airbnb has delivered a 32.2% gain over the past year, even after recent share price weakness. This puts a fresh spotlight on a simple question for investors: Is the current US$165.93 price tag adequately supported by the cash the business is expected to generate over time? The 32.2% one year return has materially changed the entry price for new buyers. The key issue is whether that move matches the strength and durability of Airbnb's cash flows. The new US$250m Housing Accelerator fund and...
NYSE:F
NYSE:FAuto

What Should Ford Motor (F) Investors Watch After Its 223,000 F 150 Recall?

Ford Motor (NYSE:F) is recalling more than 223,000 F-150 pickup trucks over a potential fuel tank strap defect. The action covers F-150 models from the 2023 through 2027 model years that may have improperly secured fuel tank straps. Ford has identified a risk that affected fuel tanks could shift or detach, raising safety concerns for drivers and passengers. The F-150 fuel tank strap recall is significant. However, Ford's broader story extends well beyond this safety issue. We have also...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium (CSTM) Stock May Be 12% Undervalued On Cash Flow

Constellium has put in a strong run over the past year, and the real question now is whether the current share price lines up with the cash flows the business is expected to generate. With the stock recently closing at US$26.19, investors are increasingly focused on what the company’s cash generation can reasonably support over time. The share price is up 60.1% over the past year, which puts the spotlight on whether that move is grounded in the cash the business can produce. The investment...
NYSE:WM
NYSE:WMCommercial Services

Can Waste Management (WM) Hold A Discount To Fair Value?

Waste Management has delivered a solid 50.4% share price gain over the past 5 years, yet the key issue for anyone looking at the stock today is how well that move lines up with the cash the business can generate. Recent leadership news only sharpens the focus on whether the current US$213.33 price is adequately grounded in the company’s cash flow profile. A 50.4% return over 5 years puts real weight on the question of whether Waste Management’s current valuation can be explained by its cash...
NYSE:WSO
NYSE:WSOTrade Distributors

Will Earnings Miss Change Watsco Stock Narrative

Watsco reported Q2 revenues of US$2.10b, which were 2.1% higher year on year but below analyst expectations, alongside a significant earnings per share shortfall versus consensus. The weak earnings print came as management pointed to a more conventional operating backdrop, where scale, OEM partnerships, and technology investments are expected to matter more for long term value creation. Investors will now assess how Watsco's investment narrative could be reshaped by the recent earnings miss...
NYSE:LEVI
NYSE:LEVILuxury

Raised 2026 Outlook Could Be A Game Changer For Levi Strauss (LEVI)

Levi Strauss reported strong recent momentum in lifestyle categories such as tops, dresses, shorts, and premium women's apparel, supported by direct-to-consumer channels. Management raised fiscal 2026 revenue and earnings guidance to reflect this broader product mix. The push beyond core denim into higher value lifestyle pieces suggests Levi Strauss is leaning on direct-to-consumer sales to support margins and reduce reliance on wholesale partners. We will look at how Levi Strauss's...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Stock Looks Fairly Priced After Its 89% Run

Coca-Cola has been a strong performer over the past few years, and the stock now trades with a long run of gains behind it. With that backdrop, the question is whether the current share price is still aligned with the cash flows the business is expected to generate. Over the past 5 years, Coca-Cola has delivered an 88.6% total return. This puts real pressure on investors to check whether the current valuation still lines up with the cash its business can produce. Planned US$10b of...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Scholar Rock Holding (SRRK) Won FDA Approval, Is The Stock Still Trading At A Discount?

Scholar Rock Holding (SRRK) just received FDA approval for ISEMBYLD, a muscle targeted therapy for spinal muscular atrophy patients already on SMN2 treatments. This has prompted a special call that puts fresh attention on the stock. Scholar Rock Holding’s share price has cooled after the FDA decision, with the stock down 12% over the past week and about 10% over the last month. However, a 15% year to date share price gain and a roughly 51% 1 year total shareholder return show momentum is...
NYSE:DOW
NYSE:DOWChemicals

Dow (DOW) Expands Polymer Distribution Reach, Is The Stock Still A Bargain?

Univar Solutions USA LLC has expanded its agreement with Dow (DOW) to distribute SupraCare polymers and specialty additives for homecare and industrial cleaning customers across the United States and Canada, widening access to these formulation ingredients. Set against that commercial update, Dow’s recent trading has softened in the short term, with the 30 day share price return down 5.45% and the 90 day share price return down 7.06%. This is occurring even though the year to date share price...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree (WT) Stock Looks Pricey Despite Its 303% Five Year Run

WisdomTree has turned into a very different stock over the past few years, and the recent share price level raises a straightforward question. Are investors paying a price that its current earnings can reasonably support, or has sentiment moved ahead of the underlying profit engine? Over the past 5 years, WisdomTree has delivered a share price return of about 302.7%, which puts a lot of pressure on its earnings to justify where the stock now trades. Record assets under management of about...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Hamilton (BAH) Stock Could Be Cheap On Current Earnings

Booz Allen Hamilton Holding has seen mixed share performance in recent years, and that uneven record puts fresh focus on whether the current price reflects what its earnings can reasonably support. With the stock moving around, the key issue is how much of the consulting group’s profit power is already embedded in today’s valuation. Over the past 3 years the share price has fallen 22.0%, which raises the question of whether the current market value still lines up with the business’s earnings...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Stock Looks Undervalued As It Jumps 24% In A Month

Salesforce has just delivered a sharp 23.8% gain over the past month, which puts fresh attention on whether the current share price lines up with what its earnings can reasonably support. With the stock last closing at US$242.85, investors are asking how much of the recent AI and product news is already embedded in that earnings picture. The 23.8% rise over the past 30 days puts recent optimism under the microscope and raises the bar for what Salesforce’s earnings need to justify. New AI...